US equity futures were flat before Monday's opening bell ahead of another week of promising crucial economic data, including jobs reports due later in the week.

Dow Jones Industrial Average futures slipped 0.1%, S&P 500 futures flatlined, and Nasdaq futures were up 0.2%.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.3% at $72.74 per barrel and US West Texas Intermediate crude 1.5% higher at $68.99 per barrel.

The S&P Global PMI manufacturing final for November will be released at 9:45 am ET, followed by the ISM Manufacturing Index for November at 10 am ET. October's construction spending bulletin is also slated for a 10 am ET release.

Employment-related reports slated for release later in the week include Job Openings and Labor Turnover Survey and jobless claims print.

In other world markets, Japan's Nikkei closed 0.8% higher, Hong Kong's Hang Seng ended 0.7% higher, and China's Shanghai Composite finished 1.1% higher. Meanwhile, the UK's FTSE 100 gained 0.5%, and Germany's DAX index rose 1.3% in Europe's early afternoon session.

In equities, Purple Biotech (PPBT) shares were up 65% pre-bell after the company said that final data from a phase 2 trial of its oncology drug candidate, CM24, demonstrated "clear and consistent improvement across all efficacy endpoints."

On the losing side, SentinelOne (S) stock was 2% lower after Morgan Stanley cut its rating to equalweight from overweight.